Characterization and bioactivities of a novel copper–zinc superoxide dismutase from the marine snail Rapana venosa: antioxidant, antimicrobial, and anticancer effects

Bibliographic Information
Authors: Saleh M.A.; Habib M.R.; AbdElGhany S.R.; Abouel-Nour M.F.; Masoud H.M.M.
Journal: Beni-Suef University Journal of Basic and Applied Sciences
Publisher: Springer Science and Business Media Deutschland GmbH
Publication Date: 9 April 2026
Volume / Issue: Volume 15 / Issue 1
Article No.: 37
ISSN: 23148535
DOI: 10.1186/s43088-026-00759-6
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Saleh M.A., Mansoura University, Al Mansurah, Egypt; Habib M.R., Theodor Bilharz Research Institute, Giza, Egypt; AbdElGhany S.R., Mansoura University, Al Mansurah, Egypt; Abouel-Nour M.F., Mansoura University, Al Mansurah, Egypt; Masoud H.M.M., National Research Centre, Cairo, Egypt
Abstract
Background: Marine organisms, particularly snails, are rich sources of bioactive compounds with potential antioxidant, antimicrobial, and anticancer properties, offering promising avenues for drug discovery. Methods: In this study, Rapana venosa extracts were evaluated for antioxidant enzyme activities and tested for antimicrobial and anticancer effects. Furthermore, a superoxide dismutase (SOD) isoenzyme, designated Rapana venosa superoxide dismutase 1 (RvSOD1), was purified from R. venosa using chromatographic techniques, characterized, and evaluated for its antimicrobial and anticancer activities. Results: The crude R. venosa extract demonstrated substantial antioxidant activity, with measurable catalase (CAT), superoxide dismutase (SOD), glutathione S-transferase (GST), and glutathione peroxidase (GPx) activities. It exhibited antimicrobial effects, inhibiting Escherichia coli by 71.2% and Candida albicans by 90.8%. The extract also showed cytotoxicity against human cancer cell lines MCF-7 (breast cancer), MDA-MB-231 (triple-negative breast cancer), and A549 (lung adenocarcinoma). The purified RvSOD1 displayed a specific activity of 600.7 U/mg (7.5-fold purification; 30.4% yield). Characterization indicated that RvSOD1 is a copper–zinc SOD, sensitive to potassium cyanide and activated by Zn2+ and Cu2+, with an optimum pH of 8.0 and an apparent molecular mass of ~ 90 kDa. Functionally, RvSOD1 showed antifungal activity against C. albicans (79.9% inhibition) and antibacterial activity against E. coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Staphylococcus aureus. In anticancer assays, RvSOD1 was active against MCF-7 and MDA-MB-231 cells but was less effective against A549 cells. Notably, the crude extract was more effective than purified RvSOD1 against all three cell lines, suggesting synergistic effects or additional bioactive compounds. Conclusion: Both the R. venosa extract and the isolated RvSOD1 possess significant antioxidant, antimicrobial, and anticancer properties. These findings highlight their potential as promising multifunctional therapeutic candidates for future pharmaceutical and biomedical applications. © The Author(s) 2026.
Keywords
Antimicrobial; Antioxidant; Antitumor; Characterization; Purification; Rapana venosa; Superoxide dismutase
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
